NovoCure (NVCR) Share-based Compensation Growth (5y) (2019 - 2026)
NovoCure (NVCR) Share-based Compensation Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.41% |
| Mar 31, 2026 | 27.28% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | 7.82% |
| Jun 30, 2025 | 6.85% |
| Mar 31, 2025 | 12.28% |
| Dec 31, 2024 | 33.69% |
| Sep 30, 2024 | 16.95% |
| Jun 30, 2024 | 18.31% |
| Mar 31, 2024 | 16.72% |
| Dec 31, 2023 | 10.38% |
| Sep 30, 2023 | 20.25% |
| Jun 30, 2023 | 26.25% |
| Mar 31, 2023 | 35.62% |
| Dec 31, 2022 | 36.19% |
| Sep 30, 2022 | 24.97% |
| Jun 30, 2022 | 27.82% |
| Mar 31, 2022 | 40.58% |
| Dec 31, 2021 | 32.81% |
| Sep 30, 2021 | 35.56% |